Additional information
White powder
90039-93-3
ACI-033111
188.1-190.2°C
C21H24O3
324.41
Ambient
2-8°C
Anti-Asthma agent
Pharmaceutical Impurity Standards
21-Hydroxypregna-1,4,9(11),16-tetraene-3,20-dione
(8S,10S,13S,14S)-17-(2-Hydroxyacetyl)-10,13-dimethyl-6,7,8,10,12,13,14,15-octahydro-3H-cyclopenta[a]phenanthren-3-one
(3aS,3bS,9aS,11aS)-1-(2-hydroxyacetyl)-9a,11a-dimethyl-3H,3aH,3bH,4H,5H,7H,9aH,11H,11aH-cyclopenta[a]phenanthren-7-one






![Ethyl (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethylsulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoate](https://staging.analyticachemie.in/wp-content/uploads/1A06130-150x150.png)


![2-sec-butyl-4-{4-[4-(4-methoxyphenyl)piperazin-1-yl]phenyl}-2H-1,2,4-triazol-3(4H)-one](https://staging.analyticachemie.in/wp-content/uploads/1A06380-150x110.png)
![Abiraterone Isopropyl Ether (25 mg) (3-((3S,8R,9S,10R,13S,14S)-3-isopropoxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl)pyridine; 3beta-Isopropoxy-17-(pyridin-3-yl)androsta-5,16-diene)](https://staging.analyticachemie.in/wp-content/uploads/image-1-150x145.png)